Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Jun 10, 2024 05:01 ET
Flash News: OKX Wallet Now Supports Moonland Meta
OKX, a leading Web3 technology company, has issued updates for June 10, 2024. OKX Wallet Now Supports Moonland Meta OKX Wallet is thrilled to announce that it has added support for Moonland Meta, a free-to-play online RPG that combines...
Jun 10, 2024 05:00 ET
Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy
Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced positive topline results from its Phase 2b RELIEF trial with licaminlimab, a novel anti-TNFα...
Jun 10, 2024 05:00 ET
Rhino Health to Deliver Enterprise Federated Computing Solutions in Collaboration With NVIDIA
Rhino Health, the global leader in federated computing, today announced a collaboration with NVIDIA to provide an enterprise-hardened federated computing solution for enterprises worldwide. This collaboration will empower organizations in...
Jun 10, 2024 05:00 ET
VEON and Kyivstar increase Ukraine investment commitment to USD 1 billion, attend Ukraine Recovery Conference in Berlin
Berlin and Kyiv, 10 June 2024: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announces that VEON, through its 100%-owned subsidiary Kyivstar, plans to...
Jun 10, 2024 04:47 ET
GKN Automotive reduces direct CO2e emissions by 10.5% in 2023
GKN Automotive, the global leader in drive systems, has published its latest Sustainability Progress Report, demonstrating the progress made in 2023 against all areas of its strategy. The company’s sustainability strategy is aligned with the UN...
Jun 10, 2024 04:00 ET
Macomics Announces Appointment of Simon Dew as New Chief Business Officer
Macomics Ltd, a leader in macrophage drug discovery has announced the appointment of Simon Dew in the newly created position of Chief Business Officer (CBO). He will be instrumental in advancing Macomics’ mission to develop first-in-class medicines...
Jun 10, 2024 04:00 ET
Cumulus Oncology Appoints Catherine Lewis La Torre to its Board of Directors
Cumulus Oncology, Europe’s first oncology-focused biotech company creation factory, announces the appointment of Catherine Lewis La Torre to its Board of Directors. Catherine brings over thirty years of investment expertise, specialising in...
Jun 10, 2024 04:00 ET
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GoodRx Holdings, Inc. (“GoodRx” or “the Company”) (NASDAQ: GDRX) and certain of its...
Jun 10, 2024 04:00 ET
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Intel Corporation (“Intel” or “the Company”) (NASDAQ: INTC) and certain of its...
Jun 10, 2024 04:00 ET
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against QuidelOrtho (“QuidelOrtho” or “the Company”) (NASDAQ: QDEL) and certain of its...
Jun 10, 2024 04:00 ET
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sharecare Inc. (“Sharecare” or “the Company”) (NASDAQ: SHCR) and certain of its officers. Class Definition:...
Jun 10, 2024 04:00 ET
SiSaf’s Bio-Courier Technology Enables Clinical Trial Success for Topical Treatment of Mild to Moderate Alopecia Areata
SiSaf Ltd, a biopharmaceutical company that has developed a range of proprietary Bio-Courier® drug delivery technologies, today announced that a licensee of the ProSilic® variant of its technology has reported positive topline results from a...
Jun 10, 2024 04:00 ET
Spherix Global Insights Expands Therapeutic Area Coverage into Hematology
Spherix Global Insights, a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry, is excited to announce its strategic expansion into coverage of the classical hematology...
Jun 10, 2024 04:00 ET
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Teladoc Health, Inc. (“Teladoc” or “the Company”) (NYSE: TDOC) and certain of its...
Jun 10, 2024 04:00 ET
VFS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that VinFast Auto Ltd. (f/k/a Black Spade Acquisition Co.) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsu
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against VinFast Auto Ltd. (f/k/a Black Spade Acquisition Co.) (“VinFast” or “the Company”)...
Jun 10, 2024 03:39 ET
Flash News: OKX Announces Launch of Fixed Simple Earn and VIP Loan
OKX, a leading crypto exchange and Web3 technology company, has issued updates for June 10, 2024. OKX Announces Launch of Fixed Simple Earn and VIP Loan OKX today announced the launch of its 'Fixed Simple Earn' and 'VIP Loan' products. Fixed...
Jun 10, 2024 03:04 ET
Flash News: OKX Wallet Now Supports Full Force
OKX, a leading Web3 technology company, has issued updates for June 10, 2024. OKX Wallet Now Supports Full Force OKX Wallet is thrilled to announce that it has added support for Full Force, the innovative community incubation platform...
Jun 10, 2024 03:00 ET
Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
US approval would make Amber-UI the first fully implantable adaptive neuromodulation therapy for women with mixed urinary incontinence (MUI)By targeting the pudendal nerve, Amber-UI has the unique potential to treat the millions of women who suffer...
Jun 10, 2024 02:18 ET
Quantexa Debuts Q Assist, New Context Aware Generative AI Technology Suite
This Monday, on the Centre Stage at London Tech Week 2024, Quantexa, the global leader in Decision Intelligence (DI) solutions for the public and private sectors debuted Q Assist, a context aware generative AI technology suite to help organizations...
Jun 10, 2024 02:00 ET
Regenx Rights Offering Fully Subscribed
Regenx Tech Corp., (the "Corporation" or "Regenx") (CSE: RGX) (OTCQB: RGXT) (FSE: YRS WKN: A2DSW3) announced today the successful completion of the previously announced rights offering (the “Offering”). In connection with the closing of the...